Quantitative image analysis of temporal changes in tau and neurofilament proteins during the course of acute experimental neurofibrillary degeneration; non-phosphorylated epitopes precede phosphorylation

Brain Research

Volumn 707, Issue 2, 1996, Pages 272-281

  Savory, John ^a   Huang, Yue ^a   Herman, Mary M ^b   Wills, Michael R ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Al maltolate; Neurofibrillary degeneration and phosphorylation sequence; Quantitative image analysis; Rabbit

Indexed keywords

ALUMINUM MALTOL; NEUROFILAMENT PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; MEDULLA OBLONGATA; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; ANTIBODIES, MONOCLONAL; EPITOPES; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MEDULLA OBLONGATA; NERVE DEGENERATION; NEUROFIBRILS; NEUROFILAMENT PROTEINS; ORGANOMETALLIC COMPOUNDS; PHOSPHORYLATION; PYRONES; RABBITS; TAU PROTEINS;

EID: 0030022195     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01264-8     Document Type: Article

References (24)

1. Bertholf, R.L., Herman, M.M., Savory, J., Carpenter, R.M., Sturgill, B.C., Katsetos, C.D., VandenBerg, S.R. and Wills, M.R., A long-term intravenous model of aluminum maltol toxicity in rabbits: tissue distribution, hepatic, renal, and neuronal cytoskeletal changes associated with systemic exposure, Toxicol. Appl. Pharmacol., 98 (1989) 58-74.
2. Crowther, R.A., Olesen, O.F., Smith, M.J., Jakes, R. and Goedert, M., Assembly of Alzheimer-like filaments from full-length tau protein, FEBS Lett., 337 (1994) 135-138.
3. Dahl, D. and Bignami, A., Immunochemical cross-reactivity of normal neurofibrils and aluminum-induced neurofibrillary tangles. Immunofluorescence study with anti-neurofilament serum, Exp. Neurol., 58 (1978) 74-80.
4. Goedert, M., Spillantini, M.G. and Jakes, R., Localization of the Alz-50 epitope in recombinant human microtubule-associated protein tau, Neurosci. Lett., 126 (1991) 149-154.
5. Goldstein, M.E., Sternberger, N.H. and Sternberger, L.A., Phosphorylation protects neurofilaments against proteolysis, J. Neuroimmunol., 14 (1987) 149-160.
6. Hsu, S., Raine, L. and Fanger, H., A comparative study of the peroxidase-antiperoxidase method and avidin method for studying polypeptide hormones with radioimmunoassay antibodies, Am. J. Clin. Pathol., 75 (1981) 734-742.
7. Huang, Y., Savory, J., Herman, M.M., Nicholson, J.R., Reyes, M.R., Boyd, J.C.and Wills, M.R., Quantitative evaluation of Al maltolate-induced neurodegeneration with subsequent Al removal by desferrioxamine treatment, NeuroToxicology, 16 (1995) 291-296.
8. Iqbal, K. and Grundke-Iqbal, I., Alzheimer's disease: From cytoskeletal protein pathology to neuronal degeneration. In K. Iqbal, D.R.C. MaLachlan, B. Winblad and H.M. Wisniewski (Eds.), Alzheimer's Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies, Wiley and Sons, USA, 1991, pp. 173-180.
9. Iqbal, K., Zaidi, T., Bancher, C.and Grundke-Iqbal, I., Alzheimer paired helical filaments. Restoration of the biological activity by dephosphorylation, FEBS Lett., 349 (1994) 104-108.
10. Katsetos, C.D., Savory, J., Herman, M.M., Carpenter, R.M., Frankfurter, A., Hewitt, C.D. and Wills, M.R., Neuronal cytoskeletal lesions induced in the CNS by intraventricular and intravenous aluminium maltol in rabbits, Neuropathol. Appl. Neurobiol., 16 (1990) 511-528.
11. Kosik, K.S., Alzheimer's disease: a cell biological perspective, Science, 256 (1992) 780-783.
12. Lichtenberg-Kraag, B., Mandelkow, E.M., Biernat, J., Steiner, B., Schroter, C., Gustke, N., Meyer, H.E. and Mandelkow, E., Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau, Proc. Natl. Acad. Sci. USA, 89 (1992) 5384-5388.
13. Matsuo, E.S., Shin, R.W., Billingsley, M.L., Van den Voorde, A., O'Connor, M., Trojanowski, J.Q. and Lee, V.M.Y., Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau, Neuron, 13 (1994) 989-1002.
14. Savory, J., Herman, M.M., Erasmus, R.T., Boyd, J.C. and Wills, M.R., Partial reversal of aluminum-induced neurofibrillary degeneration by desferrioxamine in adult male rabbits, Neuropathol. Appl. Neurobiol., 20 (1994) 31-37.
15. Savory, J., Huang, Y., Herman, M.M., Reyes, M.R. and Wills, M.R., Tau immunoreactivity associated with aluminum maltolate-induced neurofibrillary degeneration in rabbits, Brain Res., 669 (1995) 325-329.
16. Savory, J., Huang, Y., Herman, M.M., Reyes, M.R., Boyd, J.C. and Wills, M.R., Abnormal tau accumulation and partial reversal by desferrioxamine, in Al-induced neurofibrillary degeneration in rabbits. In K. Iqbal, J.A. Mortimer, B. Winblad and H.M. Wisniewski (Eds.), Research Advances in Alzheimer's Disease and Related Disorders, Wiley and Sons, USA, 1995, pp. 543-551.
17. Shin, R.W., Lee, V.M. and Trojanowski, J.Q., Aluminum modifies the properties of Alzheimer's disease PHFr proteins in vivo and in vitro, J. Neurosci, 14 (1994) 7221-7233.
18. Strong, M.J., Wolff, A.V., Wakayama, I. and Garruto, R.M., Aluminum-induced chronic myelopathy in rabbits, NeuroToxicology, 12 (1991) 9-22.
19. Terry, R.D. and Peña, C., Experimental production of neurofibrillary degeneration. 2. Electron microscopy, phosphatase histochemistry and electron probe analysis, J. Neuropathol. Exp. Neurol., 24 (1965) 200-210.
20. Trojanowski, J.Q., Schmidt, M.L., Otvos, L., Arai, H., Hill, W.D. and Lee, V.M.Y., Vulnerability of the neuronal cytoskeleton in aging and Alzheimer disease: widespread involvement of all three major filament systems, Annu. Rev. Gerontol. Geriat., 10 (1990) 167-182.
21. Trojanowski, J.Q., Schmidt, M.L., Shin, R.W., Bramblett, G.T., Goedert, M. and Lee, V.M.Y., PHF tau (A68): from pathological marker to potential mediator of neuronal dysfunction and degeneration in Alzheimer's disease, Clin. Neurosci., 1 (1993) 184-191.
22. Trojanowski, J.Q., Schmidt, M.L., Shin, R.W., Bramblett, G.T., Rao, D. and Lee, V.M.Y., Altered tau and neurofilament proteins in neurodegenerative diseases: diagnostic implications for Alzheimer's disease and Lewy body dementias, Brain Pathol., 3 (1993) 45-54.
23. Vickers, J.C., Riederer, B.M., Marugg, R.A., Buee-Scherrer, V., Buee, L., Delacourte, A. and Morrison, J.H., Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease, Neuroscience, 62 (1994) 1-13.
24. Zhang, H., Sternberger, N.H., Rubinstein, L.J., Herman, M.M., Binder, L.I. and Sternberger, L.A., Abnormal processing of multiple proteins in Alzheimer's disease, Proc. Natl. Acad. Sci. USA, 86 (1989) 8045-8049.